IN2012DN01873A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01873A
IN2012DN01873A IN1873DEN2012A IN2012DN01873A IN 2012DN01873 A IN2012DN01873 A IN 2012DN01873A IN 1873DEN2012 A IN1873DEN2012 A IN 1873DEN2012A IN 2012DN01873 A IN2012DN01873 A IN 2012DN01873A
Authority
IN
India
Prior art keywords
protective group
formula
diels
azabicyclo
hept
Prior art date
Application number
Other languages
English (en)
Inventor
Manuela Franzen
Christian Noti
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Publication of IN2012DN01873A publication Critical patent/IN2012DN01873A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/02—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IN1873DEN2012 2009-08-31 2010-08-25 IN2012DN01873A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09011146 2009-08-31
PCT/EP2010/005199 WO2011023374A1 (en) 2009-08-31 2010-08-25 Process for the preparation of (1s,4r)-2-oxa-3-azabicyclo[2,2.1]hept-5-enes

Publications (1)

Publication Number Publication Date
IN2012DN01873A true IN2012DN01873A (zh) 2015-08-21

Family

ID=41172230

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1873DEN2012 IN2012DN01873A (zh) 2009-08-31 2010-08-25

Country Status (17)

Country Link
US (1) US9102634B2 (zh)
EP (1) EP2473492B1 (zh)
JP (2) JP5955769B2 (zh)
KR (2) KR101758941B1 (zh)
CN (1) CN102482237B (zh)
AU (1) AU2010288864A1 (zh)
BR (1) BR112012004523A2 (zh)
CA (1) CA2772258C (zh)
ES (1) ES2556959T3 (zh)
HK (1) HK1168845A1 (zh)
IL (1) IL218322A0 (zh)
IN (1) IN2012DN01873A (zh)
PL (1) PL2473492T3 (zh)
SI (1) SI2473492T1 (zh)
TW (1) TWI518090B (zh)
WO (1) WO2011023374A1 (zh)
ZA (1) ZA201201715B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2794575B1 (en) 2011-12-23 2018-12-05 LEK Pharmaceuticals d.d. Synthesis of triazolopyrimidine compounds
WO2016189542A1 (en) 2015-05-28 2016-12-01 Natco Pharma Ltd Novel process for the preparation of sapropterin dihydrochloride and its key intermediate, l-biopterin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729994D0 (en) 1987-12-23 1988-02-03 Glaxo Group Ltd Chemical compounds
US5576323A (en) * 1993-12-03 1996-11-19 Eli Lilly And Company Excitatory amino acid receptor antagonists

Also Published As

Publication number Publication date
IL218322A0 (en) 2012-04-30
ES2556959T3 (es) 2016-01-21
US9102634B2 (en) 2015-08-11
KR20120092101A (ko) 2012-08-20
HK1168845A1 (zh) 2013-01-11
JP2016028038A (ja) 2016-02-25
US20120157671A1 (en) 2012-06-21
CN102482237A (zh) 2012-05-30
BR112012004523A2 (pt) 2015-09-08
TWI518090B (zh) 2016-01-21
JP5955769B2 (ja) 2016-07-20
SI2473492T1 (sl) 2016-01-29
EP2473492A1 (en) 2012-07-11
TW201109340A (en) 2011-03-16
EP2473492B1 (en) 2015-10-07
ZA201201715B (en) 2012-11-28
CN102482237B (zh) 2014-12-10
KR101758941B1 (ko) 2017-07-17
WO2011023374A1 (en) 2011-03-03
JP2013503207A (ja) 2013-01-31
KR20170015575A (ko) 2017-02-08
AU2010288864A1 (en) 2012-04-19
CA2772258C (en) 2017-11-21
PL2473492T3 (pl) 2016-03-31
JP6121492B2 (ja) 2017-04-26
CA2772258A1 (en) 2011-03-03

Similar Documents

Publication Publication Date Title
UA96015C2 (en) Therapeutic agents
UA92100C2 (uk) Похідні 1-(d-глюкопіранозил)-3-(4-циклопропілфенілметил)-4-галогеноіндолу та їх застосування як інгібіторів sglt
GEP20156348B (en) Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
MX2020012825A (es) Compuestos multiciclicos y metodos de uso de los mismos.
MY153915A (en) Organic compounds
MX2010010407A (es) Derivados de 4-aminociclohexanos sustituidos.
PL2026803T3 (pl) Kompozycje R(+) i S(-) pramipeksolu i sposoby ich zastosowania
GEP20135793B (en) Heteroaryls amide derivatives and their use as glucokinase activators
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
MX2013000733A (es) Composiciones de noribogaina.
PL1979355T3 (pl) Pochodne spiro imidazoli jako modulatory PPAR
IN2012DN02580A (zh)
IN2012DN00624A (zh)
MX2010004815A (es) Derivados de 7-azaindol como inhibidores selectivos de la 11-beta-hidroxiesteroide deshidrogenasa de tipo 1.
NO20072981L (no) Fenylpiperazinderivater med en kombinasjon av partiell dopamin-D2-receptoragonisme og serotoningjenopptaksinhibering
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
WO2011015349A3 (en) Methods for enhancing the cognitive function
MY161197A (en) Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions
GEP20156315B (en) Oxazoline and isoxazoline derivatives as crac modulators
WO2010054286A3 (en) Substituted hydroxyphenylamine compounds
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
MY183111A (en) 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
MY152475A (en) Fused ring compounds and use thereof
MY148276A (en) Long-term feed- elderly
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.